Immuneering Presents Ongoing Phase 3 MAPKeeper 301 Trial Design
Immuneering presented the design and methodology of its ongoing Phase 3 MAPKeeper 301 trial at the ESMO Congress.
Immuneering presented the design and methodology of its ongoing Phase 3 MAPKeeper 301 trial at the ESMO Congress.